Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
- Resource Type
- Article
- Source
- Targeted Oncology; Jan2022, Vol. 17 Issue 1, p43-51, 9p
- Subject
LUNG cancer SCIENTIFIC observation PHARMACOLOGY ANTINEOPLASTIC agents RETROSPECTIVE studies ANAPLASTIC lymphoma kinase PROTEIN-tyrosine kinase inhibitors CANCER patients DESCRIPTIVE statistics MENTAL illness CHEMICAL inhibitors - Language
- ISSN
- 17762596